Quick Takeaways
- JENNISON ASSOCIATES LLC filed SCHEDULE 13G/A for ARCUTIS BIOTHERAPEUTICS INC Common Stock (ARQT).
- Disclosed ownership: 9.6%.
- Date of event: 31 Mar 2025.
JENNISON ASSOCIATES LLC - 31 Mar 2025 SCHEDULE 13G/A Report for ARCUTIS BIOTHERAPEUTICS INC Common Stock (ARQT)
- Filing Manager
- JENNISON ASSOCIATES LLC
- Reporting Manager
- Jennison Associates LLC
- Symbol
- ARQT
- Shares outstanding
- 118,342,448 shares
- Disclosed Ownership
- 11,360,875 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 May 2025, 17:59:00 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 06 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JENNISON ASSOCIATES LLC disclosed 9.6% ownership in ARCUTIS BIOTHERAPEUTICS INC Common Stock (ARQT) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 May 2025, 17:59.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Jennison Associates LLC | 9.6% | 11,360,875 | 11,360,875 | 0 | Beata Markowicz | Senior Vice President, Compliance |